nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—urinary bladder cancer	0.438	1	CbGaD
Diflunisal—PTGS2—Cisplatin—urinary bladder cancer	0.064	0.225	CbGbCtD
Diflunisal—PTGS2—Etoposide—urinary bladder cancer	0.0628	0.221	CbGbCtD
Diflunisal—PTGS1—Etoposide—urinary bladder cancer	0.0531	0.187	CbGbCtD
Diflunisal—ALB—Fluorouracil—urinary bladder cancer	0.0475	0.167	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—urinary bladder cancer	0.0307	0.108	CbGbCtD
Diflunisal—ALB—Methotrexate—urinary bladder cancer	0.0262	0.0921	CbGbCtD
Diflunisal—TTR—urine—urinary bladder cancer	0.00816	0.286	CbGeAlD
Diflunisal—UGT1A8—renal system—urinary bladder cancer	0.00435	0.153	CbGeAlD
Diflunisal—TTR—renal system—urinary bladder cancer	0.002	0.0701	CbGeAlD
Diflunisal—TTR—female reproductive system—urinary bladder cancer	0.0016	0.0561	CbGeAlD
Diflunisal—Flurbiprofen—UGT2B7—urinary bladder cancer	0.00142	0.175	CrCbGaD
Diflunisal—Aminosalicylic Acid—MPO—urinary bladder cancer	0.00128	0.158	CrCbGaD
Diflunisal—Olsalazine—PPARG—urinary bladder cancer	0.00121	0.149	CrCbGaD
Diflunisal—PTGS1—prostate gland—urinary bladder cancer	0.00107	0.0374	CbGeAlD
Diflunisal—PTGS2—prostate gland—urinary bladder cancer	0.00102	0.0357	CbGeAlD
Diflunisal—Mesalazine—MPO—urinary bladder cancer	0.001	0.124	CrCbGaD
Diflunisal—PTGS1—seminal vesicle—urinary bladder cancer	0.000901	0.0316	CbGeAlD
Diflunisal—Mesalazine—PPARG—urinary bladder cancer	0.000891	0.11	CrCbGaD
Diflunisal—PTGS2—seminal vesicle—urinary bladder cancer	0.000861	0.0302	CbGeAlD
Diflunisal—PTGS1—epithelium—urinary bladder cancer	0.000783	0.0275	CbGeAlD
Diflunisal—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000754	0.0265	CbGeAlD
Diflunisal—PTGS2—epithelium—urinary bladder cancer	0.000748	0.0263	CbGeAlD
Diflunisal—PTGS1—renal system—urinary bladder cancer	0.000726	0.0255	CbGeAlD
Diflunisal—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000721	0.0253	CbGeAlD
Diflunisal—PTGS2—renal system—urinary bladder cancer	0.000694	0.0244	CbGeAlD
Diflunisal—PTGS2—urethra—urinary bladder cancer	0.000682	0.0239	CbGeAlD
Diflunisal—ALB—lymph node—urinary bladder cancer	0.000597	0.021	CbGeAlD
Diflunisal—PTGS1—female reproductive system—urinary bladder cancer	0.000582	0.0204	CbGeAlD
Diflunisal—PTGS2—female reproductive system—urinary bladder cancer	0.000556	0.0195	CbGeAlD
Diflunisal—PTGS1—vagina—urinary bladder cancer	0.000526	0.0185	CbGeAlD
Diflunisal—Olsalazine—PTGS2—urinary bladder cancer	0.00051	0.063	CrCbGaD
Diflunisal—PTGS2—vagina—urinary bladder cancer	0.000503	0.0176	CbGeAlD
Diflunisal—Aminosalicylic Acid—PTGS2—urinary bladder cancer	0.000479	0.0592	CrCbGaD
Diflunisal—Salsalate—PTGS2—urinary bladder cancer	0.000433	0.0535	CrCbGaD
Diflunisal—Mesalazine—PTGS2—urinary bladder cancer	0.000376	0.0465	CrCbGaD
Diflunisal—PTGS1—lymph node—urinary bladder cancer	0.00034	0.0119	CbGeAlD
Diflunisal—PTGS2—lymph node—urinary bladder cancer	0.000325	0.0114	CbGeAlD
Diflunisal—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000306	0.00234	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000304	0.00232	CcSEcCtD
Diflunisal—Anorexia—Gemcitabine—urinary bladder cancer	0.000303	0.00231	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—urinary bladder cancer	0.000301	0.0023	CcSEcCtD
Diflunisal—Urticaria—Thiotepa—urinary bladder cancer	0.0003	0.00229	CcSEcCtD
Diflunisal—Vertigo—Etoposide—urinary bladder cancer	0.000299	0.00228	CcSEcCtD
Diflunisal—Body temperature increased—Thiotepa—urinary bladder cancer	0.000299	0.00228	CcSEcCtD
Diflunisal—Anorexia—Fluorouracil—urinary bladder cancer	0.000298	0.00228	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000298	0.00227	CcSEcCtD
Diflunisal—Oedema—Cisplatin—urinary bladder cancer	0.000296	0.00226	CcSEcCtD
Diflunisal—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000296	0.00226	CcSEcCtD
Diflunisal—Loss of consciousness—Etoposide—urinary bladder cancer	0.000292	0.00223	CcSEcCtD
Diflunisal—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00029	0.00222	CcSEcCtD
Diflunisal—Insomnia—Gemcitabine—urinary bladder cancer	0.000288	0.0022	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000287	0.00219	CcSEcCtD
Diflunisal—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000287	0.00219	CcSEcCtD
Diflunisal—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000286	0.00218	CcSEcCtD
Diflunisal—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000284	0.00216	CcSEcCtD
Diflunisal—Chest pain—Etoposide—urinary bladder cancer	0.000283	0.00216	CcSEcCtD
Diflunisal—Insomnia—Fluorouracil—urinary bladder cancer	0.000283	0.00216	CcSEcCtD
Diflunisal—Somnolence—Gemcitabine—urinary bladder cancer	0.000283	0.00216	CcSEcCtD
Diflunisal—Anorexia—Cisplatin—urinary bladder cancer	0.000283	0.00216	CcSEcCtD
Diflunisal—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000281	0.00214	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000279	0.00213	CcSEcCtD
Diflunisal—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000279	0.00213	CcSEcCtD
Diflunisal—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000279	0.00213	CcSEcCtD
Diflunisal—Somnolence—Fluorouracil—urinary bladder cancer	0.000278	0.00212	CcSEcCtD
Diflunisal—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000276	0.00211	CcSEcCtD
Diflunisal—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000275	0.0021	CcSEcCtD
Diflunisal—Fatigue—Gemcitabine—urinary bladder cancer	0.000274	0.00209	CcSEcCtD
Diflunisal—Gastritis—Epirubicin—urinary bladder cancer	0.000274	0.00209	CcSEcCtD
Diflunisal—Confusional state—Etoposide—urinary bladder cancer	0.000274	0.00209	CcSEcCtD
Diflunisal—Constipation—Gemcitabine—urinary bladder cancer	0.000272	0.00208	CcSEcCtD
Diflunisal—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000272	0.00207	CcSEcCtD
Diflunisal—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000272	0.00207	CcSEcCtD
Diflunisal—Asthenia—Thiotepa—urinary bladder cancer	0.000271	0.00207	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—urinary bladder cancer	0.000267	0.00204	CcSEcCtD
Diflunisal—Pruritus—Thiotepa—urinary bladder cancer	0.000267	0.00204	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—urinary bladder cancer	0.000267	0.0329	CrCbGaD
Diflunisal—Paraesthesia—Cisplatin—urinary bladder cancer	0.000266	0.00203	CcSEcCtD
Diflunisal—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000266	0.00203	CcSEcCtD
Diflunisal—Dyspnoea—Cisplatin—urinary bladder cancer	0.000264	0.00202	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000263	0.002	CcSEcCtD
Diflunisal—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000262	0.002	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000261	0.00199	CcSEcCtD
Diflunisal—Anorexia—Etoposide—urinary bladder cancer	0.000259	0.00198	CcSEcCtD
Diflunisal—Diarrhoea—Thiotepa—urinary bladder cancer	0.000259	0.00197	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000258	0.00197	CcSEcCtD
Diflunisal—Decreased appetite—Cisplatin—urinary bladder cancer	0.000258	0.00197	CcSEcCtD
Diflunisal—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000258	0.00197	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—urinary bladder cancer	0.000254	0.00194	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000253	0.00193	CcSEcCtD
Diflunisal—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000251	0.00192	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—urinary bladder cancer	0.000251	0.00191	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—urinary bladder cancer	0.00025	0.00191	CcSEcCtD
Diflunisal—Dizziness—Thiotepa—urinary bladder cancer	0.00025	0.00191	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—urinary bladder cancer	0.000249	0.0019	CcSEcCtD
Diflunisal—Urticaria—Fluorouracil—urinary bladder cancer	0.000248	0.0019	CcSEcCtD
Diflunisal—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000247	0.00189	CcSEcCtD
Diflunisal—Sweating—Methotrexate—urinary bladder cancer	0.000245	0.00187	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000244	0.00186	CcSEcCtD
Diflunisal—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000244	0.00186	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—urinary bladder cancer	0.000244	0.00186	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—urinary bladder cancer	0.000243	0.00186	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—urinary bladder cancer	0.000242	0.00185	CcSEcCtD
Diflunisal—Somnolence—Etoposide—urinary bladder cancer	0.000241	0.00184	CcSEcCtD
Diflunisal—Vomiting—Thiotepa—urinary bladder cancer	0.00024	0.00183	CcSEcCtD
Diflunisal—Rash—Thiotepa—urinary bladder cancer	0.000238	0.00182	CcSEcCtD
Diflunisal—Dermatitis—Thiotepa—urinary bladder cancer	0.000238	0.00182	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000238	0.00182	CcSEcCtD
Diflunisal—Headache—Thiotepa—urinary bladder cancer	0.000237	0.00181	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000237	0.00181	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—urinary bladder cancer	0.000236	0.0018	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—urinary bladder cancer	0.000235	0.00179	CcSEcCtD
Diflunisal—Body temperature increased—Cisplatin—urinary bladder cancer	0.000234	0.00179	CcSEcCtD
Diflunisal—Fatigue—Etoposide—urinary bladder cancer	0.000234	0.00179	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—urinary bladder cancer	0.000234	0.0289	CrCbGaD
Diflunisal—Jaundice—Epirubicin—urinary bladder cancer	0.000233	0.00178	CcSEcCtD
Diflunisal—Stomatitis—Epirubicin—urinary bladder cancer	0.000233	0.00178	CcSEcCtD
Diflunisal—Constipation—Etoposide—urinary bladder cancer	0.000232	0.00177	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—urinary bladder cancer	0.000232	0.00177	CcSEcCtD
Diflunisal—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00023	0.00176	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—urinary bladder cancer	0.000229	0.00175	CcSEcCtD
Diflunisal—Sweating—Epirubicin—urinary bladder cancer	0.000229	0.00175	CcSEcCtD
Diflunisal—Asthenia—Gemcitabine—urinary bladder cancer	0.000228	0.00174	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—urinary bladder cancer	0.000228	0.00174	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000226	0.00173	CcSEcCtD
Diflunisal—Pruritus—Gemcitabine—urinary bladder cancer	0.000225	0.00172	CcSEcCtD
Diflunisal—Nausea—Thiotepa—urinary bladder cancer	0.000225	0.00171	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—urinary bladder cancer	0.000224	0.00171	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000223	0.0017	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000222	0.00169	CcSEcCtD
Diflunisal—Pruritus—Fluorouracil—urinary bladder cancer	0.000221	0.00169	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—urinary bladder cancer	0.000221	0.00168	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000219	0.00167	CcSEcCtD
Diflunisal—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000218	0.00167	CcSEcCtD
Diflunisal—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000218	0.00166	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—urinary bladder cancer	0.000217	0.00166	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000216	0.00165	CcSEcCtD
Diflunisal—Urticaria—Etoposide—urinary bladder cancer	0.000216	0.00165	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—urinary bladder cancer	0.000215	0.00164	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—urinary bladder cancer	0.000215	0.00164	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—urinary bladder cancer	0.000215	0.00164	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—urinary bladder cancer	0.000214	0.00164	CcSEcCtD
Diflunisal—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000214	0.00163	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—urinary bladder cancer	0.000213	0.00163	CcSEcCtD
Diflunisal—Asthenia—Cisplatin—urinary bladder cancer	0.000213	0.00162	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—urinary bladder cancer	0.000212	0.00162	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—urinary bladder cancer	0.000211	0.00161	CcSEcCtD
Diflunisal—Dizziness—Fluorouracil—urinary bladder cancer	0.000207	0.00158	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—urinary bladder cancer	0.000206	0.00158	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000206	0.00157	CcSEcCtD
Diflunisal—Diarrhoea—Cisplatin—urinary bladder cancer	0.000203	0.00155	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000203	0.00155	CcSEcCtD
Diflunisal—Vomiting—Gemcitabine—urinary bladder cancer	0.000202	0.00154	CcSEcCtD
Diflunisal—Rash—Gemcitabine—urinary bladder cancer	0.000201	0.00153	CcSEcCtD
Diflunisal—Dermatitis—Gemcitabine—urinary bladder cancer	0.0002	0.00153	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—urinary bladder cancer	0.0002	0.00153	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—urinary bladder cancer	0.0002	0.00152	CcSEcCtD
Diflunisal—Headache—Gemcitabine—urinary bladder cancer	0.000199	0.00152	CcSEcCtD
Diflunisal—Flushing—Epirubicin—urinary bladder cancer	0.000199	0.00152	CcSEcCtD
Diflunisal—Vomiting—Fluorouracil—urinary bladder cancer	0.000199	0.00152	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—urinary bladder cancer	0.000198	0.00151	CcSEcCtD
Diflunisal—Rash—Fluorouracil—urinary bladder cancer	0.000197	0.0015	CcSEcCtD
Diflunisal—Dermatitis—Fluorouracil—urinary bladder cancer	0.000197	0.0015	CcSEcCtD
Diflunisal—Headache—Fluorouracil—urinary bladder cancer	0.000196	0.0015	CcSEcCtD
Diflunisal—Asthenia—Etoposide—urinary bladder cancer	0.000195	0.00149	CcSEcCtD
Diflunisal—Pruritus—Etoposide—urinary bladder cancer	0.000192	0.00147	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—urinary bladder cancer	0.000191	0.00146	CcSEcCtD
Diflunisal—Nausea—Gemcitabine—urinary bladder cancer	0.000189	0.00144	CcSEcCtD
Diflunisal—Vomiting—Cisplatin—urinary bladder cancer	0.000188	0.00144	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—urinary bladder cancer	0.000188	0.00143	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000187	0.00143	CcSEcCtD
Diflunisal—Rash—Cisplatin—urinary bladder cancer	0.000187	0.00143	CcSEcCtD
Diflunisal—Dermatitis—Cisplatin—urinary bladder cancer	0.000187	0.00143	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—urinary bladder cancer	0.000186	0.00142	CcSEcCtD
Diflunisal—Nausea—Fluorouracil—urinary bladder cancer	0.000186	0.00142	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—urinary bladder cancer	0.000185	0.00141	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—urinary bladder cancer	0.000184	0.0014	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—urinary bladder cancer	0.000184	0.0014	CcSEcCtD
Diflunisal—Tension—Epirubicin—urinary bladder cancer	0.000183	0.0014	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—urinary bladder cancer	0.000181	0.00138	CcSEcCtD
Diflunisal—Dizziness—Etoposide—urinary bladder cancer	0.00018	0.00137	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—urinary bladder cancer	0.000179	0.00137	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—urinary bladder cancer	0.000179	0.00137	CcSEcCtD
Diflunisal—Nausea—Cisplatin—urinary bladder cancer	0.000176	0.00134	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—urinary bladder cancer	0.000176	0.00134	CcSEcCtD
Diflunisal—Vomiting—Etoposide—urinary bladder cancer	0.000173	0.00132	CcSEcCtD
Diflunisal—Rash—Etoposide—urinary bladder cancer	0.000171	0.00131	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—urinary bladder cancer	0.000171	0.00131	CcSEcCtD
Diflunisal—Headache—Etoposide—urinary bladder cancer	0.00017	0.0013	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—urinary bladder cancer	0.00017	0.0013	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—urinary bladder cancer	0.00017	0.0013	CcSEcCtD
Diflunisal—Tension—Doxorubicin—urinary bladder cancer	0.000169	0.00129	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—urinary bladder cancer	0.000168	0.00128	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—urinary bladder cancer	0.000168	0.00128	CcSEcCtD
Diflunisal—Syncope—Epirubicin—urinary bladder cancer	0.000167	0.00128	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000166	0.00127	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—urinary bladder cancer	0.000165	0.00126	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—urinary bladder cancer	0.000164	0.00125	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000164	0.00125	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000163	0.00124	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—urinary bladder cancer	0.000163	0.00124	CcSEcCtD
Diflunisal—Nausea—Etoposide—urinary bladder cancer	0.000161	0.00123	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000159	0.00122	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—urinary bladder cancer	0.000159	0.00121	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000157	0.0012	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—urinary bladder cancer	0.000155	0.00118	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—urinary bladder cancer	0.000155	0.00118	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—urinary bladder cancer	0.000155	0.00118	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—urinary bladder cancer	0.000153	0.00117	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—urinary bladder cancer	0.000153	0.00116	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000152	0.00116	CcSEcCtD
Diflunisal—Oedema—Epirubicin—urinary bladder cancer	0.000152	0.00116	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000152	0.00116	CcSEcCtD
Diflunisal—Shock—Epirubicin—urinary bladder cancer	0.00015	0.00114	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000149	0.00114	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000147	0.00112	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—urinary bladder cancer	0.000147	0.00112	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—urinary bladder cancer	0.000147	0.00112	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—urinary bladder cancer	0.000146	0.00111	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—urinary bladder cancer	0.000145	0.00111	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—urinary bladder cancer	0.000145	0.00111	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—urinary bladder cancer	0.000145	0.0011	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—urinary bladder cancer	0.000143	0.00109	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—urinary bladder cancer	0.000142	0.00108	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—urinary bladder cancer	0.000141	0.00108	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000141	0.00108	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—urinary bladder cancer	0.000141	0.00108	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—urinary bladder cancer	0.00014	0.00107	CcSEcCtD
Diflunisal—Shock—Doxorubicin—urinary bladder cancer	0.000139	0.00106	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000138	0.00105	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—urinary bladder cancer	0.000138	0.00105	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—urinary bladder cancer	0.000137	0.00104	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000136	0.00104	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—urinary bladder cancer	0.000136	0.00104	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—urinary bladder cancer	0.000135	0.00103	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—urinary bladder cancer	0.000134	0.00102	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000134	0.00102	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—urinary bladder cancer	0.000134	0.00102	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000133	0.00102	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—urinary bladder cancer	0.000132	0.00101	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—urinary bladder cancer	0.000131	0.001	CcSEcCtD
Diflunisal—Constipation—Epirubicin—urinary bladder cancer	0.00013	0.000994	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—urinary bladder cancer	0.000129	0.000986	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—urinary bladder cancer	0.000129	0.000981	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—urinary bladder cancer	0.000127	0.000972	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000126	0.000965	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000126	0.000958	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000125	0.000957	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—urinary bladder cancer	0.000125	0.000956	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000124	0.00095	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000124	0.000946	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000122	0.000935	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—urinary bladder cancer	0.000121	0.000927	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—urinary bladder cancer	0.000121	0.000923	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—urinary bladder cancer	0.00012	0.000919	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—urinary bladder cancer	0.00012	0.000919	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00012	0.000915	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—urinary bladder cancer	0.000117	0.000891	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000116	0.000886	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000115	0.000879	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—urinary bladder cancer	0.000115	0.000878	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	0.000114	0.00104	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NQO1—urinary bladder cancer	0.000114	0.00104	CbGpPWpGaD
Diflunisal—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000112	0.000856	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—urinary bladder cancer	0.000112	0.000854	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000111	0.00085	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—urinary bladder cancer	0.000111	0.000849	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	0.000109	0.000995	CbGpPWpGaD
Diflunisal—Asthenia—Epirubicin—urinary bladder cancer	0.000109	0.000834	CcSEcCtD
Diflunisal—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000108	0.000987	CbGpPWpGaD
Diflunisal—Pruritus—Epirubicin—urinary bladder cancer	0.000108	0.000822	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—urinary bladder cancer	0.000108	0.000821	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—urinary bladder cancer	0.000104	0.000795	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000104	0.000792	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—urinary bladder cancer	0.000103	0.000789	CcSEcCtD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000103	0.000941	CbGpPWpGaD
Diflunisal—Rash—Methotrexate—urinary bladder cancer	0.000103	0.000783	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—urinary bladder cancer	0.000102	0.000782	CcSEcCtD
Diflunisal—TTR—Disease—JAG1—urinary bladder cancer	0.000102	0.000929	CbGpPWpGaD
Diflunisal—Headache—Methotrexate—urinary bladder cancer	0.000102	0.000778	CcSEcCtD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000101	0.000922	CbGpPWpGaD
Diflunisal—Asthenia—Doxorubicin—urinary bladder cancer	0.000101	0.000771	CcSEcCtD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000101	0.00092	CbGpPWpGaD
Diflunisal—Dizziness—Epirubicin—urinary bladder cancer	0.000101	0.000768	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—urinary bladder cancer	9.96e-05	0.000761	CcSEcCtD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9.94e-05	0.000905	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	9.91e-05	0.000902	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	9.85e-05	0.000897	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL2—urinary bladder cancer	9.72e-05	0.000885	CbGpPWpGaD
Diflunisal—Vomiting—Epirubicin—urinary bladder cancer	9.68e-05	0.000739	CcSEcCtD
Diflunisal—Nausea—Methotrexate—urinary bladder cancer	9.66e-05	0.000737	CcSEcCtD
Diflunisal—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	9.66e-05	0.000879	CbGpPWpGaD
Diflunisal—Diarrhoea—Doxorubicin—urinary bladder cancer	9.64e-05	0.000736	CcSEcCtD
Diflunisal—Rash—Epirubicin—urinary bladder cancer	9.6e-05	0.000733	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—urinary bladder cancer	9.59e-05	0.000732	CcSEcCtD
Diflunisal—Headache—Epirubicin—urinary bladder cancer	9.54e-05	0.000728	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—GSTP1—urinary bladder cancer	9.5e-05	0.000865	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	9.34e-05	0.000851	CbGpPWpGaD
Diflunisal—Dizziness—Doxorubicin—urinary bladder cancer	9.31e-05	0.000711	CcSEcCtD
Diflunisal—Nausea—Epirubicin—urinary bladder cancer	9.04e-05	0.00069	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	9e-05	0.000819	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	8.97e-05	0.000817	CbGpPWpGaD
Diflunisal—Vomiting—Doxorubicin—urinary bladder cancer	8.96e-05	0.000684	CcSEcCtD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.93e-05	0.000813	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	8.89e-05	0.000809	CbGpPWpGaD
Diflunisal—Rash—Doxorubicin—urinary bladder cancer	8.88e-05	0.000678	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—urinary bladder cancer	8.87e-05	0.000677	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—TYMS—urinary bladder cancer	8.83e-05	0.000804	CbGpPWpGaD
Diflunisal—Headache—Doxorubicin—urinary bladder cancer	8.82e-05	0.000673	CcSEcCtD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.81e-05	0.000802	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	8.76e-05	0.000797	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GSTM1—urinary bladder cancer	8.73e-05	0.000795	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NCOR1—urinary bladder cancer	8.73e-05	0.000795	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	8.7e-05	0.000792	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTO2—urinary bladder cancer	8.51e-05	0.000775	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NAT1—urinary bladder cancer	8.51e-05	0.000775	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.43e-05	0.000768	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.37e-05	0.000762	CbGpPWpGaD
Diflunisal—Nausea—Doxorubicin—urinary bladder cancer	8.37e-05	0.000639	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—GPX1—urinary bladder cancer	8.36e-05	0.000761	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	8.33e-05	0.000759	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ERCC2—urinary bladder cancer	8.21e-05	0.000747	CbGpPWpGaD
Diflunisal—PTGS2—Disease—GSTO2—urinary bladder cancer	8.06e-05	0.000734	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RBX1—urinary bladder cancer	7.98e-05	0.000727	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	7.9e-05	0.000719	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.78e-05	0.000709	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	7.78e-05	0.000708	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.75e-05	0.000706	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	7.75e-05	0.000705	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.72e-05	0.000703	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—MTHFR—urinary bladder cancer	7.72e-05	0.000702	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	7.55e-05	0.000687	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TSC1—urinary bladder cancer	7.5e-05	0.000683	CbGpPWpGaD
Diflunisal—TTR—Disease—NCOR1—urinary bladder cancer	7.43e-05	0.000676	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	7.36e-05	0.00067	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	7.16e-05	0.000652	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	7.14e-05	0.00065	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—JAG1—urinary bladder cancer	7.14e-05	0.00065	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	7.12e-05	0.000649	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—urinary bladder cancer	7.08e-05	0.000645	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.01e-05	0.000638	CbGpPWpGaD
Diflunisal—TTR—Disease—ERCC2—urinary bladder cancer	6.98e-05	0.000636	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.95e-05	0.000633	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.88e-05	0.000626	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.77e-05	0.000616	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTO2—urinary bladder cancer	6.75e-05	0.000615	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NAT1—urinary bladder cancer	6.75e-05	0.000615	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.68e-05	0.000608	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.64e-05	0.000605	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	6.62e-05	0.000602	CbGpPWpGaD
Diflunisal—TTR—Disease—MTHFR—urinary bladder cancer	6.56e-05	0.000598	CbGpPWpGaD
Diflunisal—TTR—Disease—TERT—urinary bladder cancer	6.55e-05	0.000596	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PRSS3—urinary bladder cancer	6.45e-05	0.000587	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC19A1—urinary bladder cancer	6.27e-05	0.000571	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PPARG—urinary bladder cancer	6.26e-05	0.00057	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—urinary bladder cancer	6.24e-05	0.000568	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	6.18e-05	0.000562	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PRSS3—urinary bladder cancer	6.11e-05	0.000556	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	6.08e-05	0.000554	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CREBBP—urinary bladder cancer	6.01e-05	0.000547	CbGpPWpGaD
Diflunisal—TTR—Disease—FGFR3—urinary bladder cancer	6.01e-05	0.000547	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	5.9e-05	0.000537	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HDAC4—urinary bladder cancer	5.83e-05	0.000531	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—S100B—urinary bladder cancer	5.78e-05	0.000527	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	5.77e-05	0.000526	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTZ1—urinary bladder cancer	5.76e-05	0.000525	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.67e-05	0.000516	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.62e-05	0.000512	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	5.56e-05	0.000506	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	5.5e-05	0.000501	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTO2—urinary bladder cancer	5.46e-05	0.000497	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NAT1—urinary bladder cancer	5.46e-05	0.000497	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.37e-05	0.000489	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	5.25e-05	0.000478	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NCOR1—urinary bladder cancer	5.2e-05	0.000474	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.17e-05	0.000471	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.15e-05	0.000469	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PRSS3—urinary bladder cancer	5.12e-05	0.000466	CbGpPWpGaD
Diflunisal—TTR—Disease—CREBBP—urinary bladder cancer	5.11e-05	0.000466	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.01e-05	0.000456	CbGpPWpGaD
Diflunisal—ALB—Metabolism—UGT2B7—urinary bladder cancer	5e-05	0.000455	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.95e-05	0.000451	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—urinary bladder cancer	4.92e-05	0.000448	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	4.85e-05	0.000441	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.84e-05	0.000441	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.83e-05	0.00044	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	4.81e-05	0.000438	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.66e-05	0.000424	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.64e-05	0.000423	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LIG1—urinary bladder cancer	4.63e-05	0.000422	CbGpPWpGaD
Diflunisal—TTR—Disease—RHOA—urinary bladder cancer	4.63e-05	0.000421	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.61e-05	0.00042	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TERT—urinary bladder cancer	4.58e-05	0.000417	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP4B1—urinary bladder cancer	4.5e-05	0.00041	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.48e-05	0.000408	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	4.41e-05	0.000401	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTEN—urinary bladder cancer	4.29e-05	0.000391	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IFNA2—urinary bladder cancer	4.29e-05	0.00039	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB2—urinary bladder cancer	4.28e-05	0.00039	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC19A1—urinary bladder cancer	4.25e-05	0.000387	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FGFR3—urinary bladder cancer	4.21e-05	0.000383	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—urinary bladder cancer	4.19e-05	0.000381	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.18e-05	0.000381	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PRSS3—urinary bladder cancer	4.14e-05	0.000377	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.1e-05	0.000374	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—EP300—urinary bladder cancer	4.09e-05	0.000373	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMP—urinary bladder cancer	4.09e-05	0.000373	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ESR1—urinary bladder cancer	4.09e-05	0.000372	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.02e-05	0.000366	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.02e-05	0.000366	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.93e-05	0.000358	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.93e-05	0.000358	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.74e-05	0.000341	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.73e-05	0.000339	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.73e-05	0.000339	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.71e-05	0.000338	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.7e-05	0.000337	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.7e-05	0.000337	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	3.7e-05	0.000337	CbGpPWpGaD
Diflunisal—TTR—Disease—CDKN1A—urinary bladder cancer	3.66e-05	0.000333	CbGpPWpGaD
Diflunisal—TTR—Disease—PTEN—urinary bladder cancer	3.65e-05	0.000332	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.61e-05	0.000329	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CREBBP—urinary bladder cancer	3.58e-05	0.000326	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.56e-05	0.000324	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IGF1—urinary bladder cancer	3.54e-05	0.000322	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ENO2—urinary bladder cancer	3.53e-05	0.000322	CbGpPWpGaD
Diflunisal—TTR—Disease—EP300—urinary bladder cancer	3.48e-05	0.000317	CbGpPWpGaD
Diflunisal—TTR—Disease—SRC—urinary bladder cancer	3.39e-05	0.000308	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RBX1—urinary bladder cancer	3.35e-05	0.000305	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.32e-05	0.000302	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMP—urinary bladder cancer	3.31e-05	0.000301	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.3e-05	0.0003	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RHOA—urinary bladder cancer	3.24e-05	0.000295	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	3.23e-05	0.000294	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—RRM2—urinary bladder cancer	3.19e-05	0.000291	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.18e-05	0.000289	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLAU—urinary bladder cancer	3.04e-05	0.000277	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—urinary bladder cancer	3.03e-05	0.000276	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NQO1—urinary bladder cancer	3e-05	0.000273	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—urinary bladder cancer	3e-05	0.000273	CbGpPWpGaD
Diflunisal—PTGS2—Disease—JAG1—urinary bladder cancer	3e-05	0.000273	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NAT2—urinary bladder cancer	2.99e-05	0.000273	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—urinary bladder cancer	2.97e-05	0.00027	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.96e-05	0.000269	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.96e-05	0.000269	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.94e-05	0.000268	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.91e-05	0.000265	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.87e-05	0.000261	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—urinary bladder cancer	2.84e-05	0.000259	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.83e-05	0.000257	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—urinary bladder cancer	2.8e-05	0.000255	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—urinary bladder cancer	2.72e-05	0.000247	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—urinary bladder cancer	2.65e-05	0.000241	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RRM2—urinary bladder cancer	2.58e-05	0.000235	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—urinary bladder cancer	2.57e-05	0.000234	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1A—urinary bladder cancer	2.56e-05	0.000233	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—urinary bladder cancer	2.56e-05	0.000233	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.54e-05	0.000231	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CREBBP—urinary bladder cancer	2.51e-05	0.000229	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.51e-05	0.000228	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IGF1—urinary bladder cancer	2.48e-05	0.000226	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EP300—urinary bladder cancer	2.44e-05	0.000222	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.42e-05	0.000221	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ENO2—urinary bladder cancer	2.39e-05	0.000218	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HPGDS—urinary bladder cancer	2.39e-05	0.000218	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.38e-05	0.000217	CbGpPWpGaD
Diflunisal—TTR—Disease—HRAS—urinary bladder cancer	2.38e-05	0.000217	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.38e-05	0.000217	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SRC—urinary bladder cancer	2.37e-05	0.000216	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.33e-05	0.000212	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—urinary bladder cancer	2.32e-05	0.000211	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.3e-05	0.00021	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.3e-05	0.00021	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.29e-05	0.000208	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RHOA—urinary bladder cancer	2.27e-05	0.000207	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.2e-05	0.000201	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NCOR1—urinary bladder cancer	2.18e-05	0.000199	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.17e-05	0.000198	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.16e-05	0.000197	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—urinary bladder cancer	2.13e-05	0.000193	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—urinary bladder cancer	2.08e-05	0.000189	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERCC2—urinary bladder cancer	2.05e-05	0.000187	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.03e-05	0.000185	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.02e-05	0.000184	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.99e-05	0.000181	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—urinary bladder cancer	1.96e-05	0.000179	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NQO1—urinary bladder cancer	1.93e-05	0.000176	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTHFR—urinary bladder cancer	1.93e-05	0.000176	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.92e-05	0.000175	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TERT—urinary bladder cancer	1.92e-05	0.000175	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—urinary bladder cancer	1.91e-05	0.000173	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.87e-05	0.00017	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.85e-05	0.000168	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.83e-05	0.000166	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.83e-05	0.000166	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FGFR3—urinary bladder cancer	1.76e-05	0.000161	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.75e-05	0.000159	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—urinary bladder cancer	1.75e-05	0.000159	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.72e-05	0.000156	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—EP300—urinary bladder cancer	1.71e-05	0.000156	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HRAS—urinary bladder cancer	1.67e-05	0.000152	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SRC—urinary bladder cancer	1.66e-05	0.000151	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.65e-05	0.00015	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.63e-05	0.000149	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.62e-05	0.000147	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—urinary bladder cancer	1.61e-05	0.000146	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.58e-05	0.000144	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.56e-05	0.000142	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CREBBP—urinary bladder cancer	1.5e-05	0.000137	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMS—urinary bladder cancer	1.5e-05	0.000136	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NCOR1—urinary bladder cancer	1.48e-05	0.000135	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—urinary bladder cancer	1.48e-05	0.000135	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPX1—urinary bladder cancer	1.42e-05	0.000129	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ERCC2—urinary bladder cancer	1.39e-05	0.000127	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—urinary bladder cancer	1.38e-05	0.000125	CbGpPWpGaD
Diflunisal—PTGS2—Disease—RHOA—urinary bladder cancer	1.36e-05	0.000124	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.31e-05	0.000119	CbGpPWpGaD
Diflunisal—ALB—Metabolism—MTHFR—urinary bladder cancer	1.31e-05	0.000119	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.3e-05	0.000118	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.26e-05	0.000115	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—urinary bladder cancer	1.26e-05	0.000115	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—urinary bladder cancer	1.22e-05	0.000111	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HRAS—urinary bladder cancer	1.17e-05	0.000107	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.13e-05	0.000103	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—EP300—urinary bladder cancer	1.08e-05	9.83e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.08e-05	9.79e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—urinary bladder cancer	1.07e-05	9.77e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPARG—urinary bladder cancer	1.06e-05	9.65e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EP300—urinary bladder cancer	1.02e-05	9.32e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CREBBP—urinary bladder cancer	1.02e-05	9.27e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SRC—urinary bladder cancer	9.95e-06	9.06e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—urinary bladder cancer	8.99e-06	8.18e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—urinary bladder cancer	8.92e-06	8.12e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—urinary bladder cancer	8.72e-06	7.94e-05	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—EP300—urinary bladder cancer	8.57e-06	7.8e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—urinary bladder cancer	8.34e-06	7.59e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—urinary bladder cancer	8.24e-06	7.5e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—urinary bladder cancer	7.27e-06	6.62e-05	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HRAS—urinary bladder cancer	7e-06	6.38e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—EP300—urinary bladder cancer	6.93e-06	6.31e-05	CbGpPWpGaD
